HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Esthesioneuroblastoma

Esthesioneuroblastoma

Esthesioneuroblastoma, a rare type of cancer, arises from the olfactory epithelium in the nasal cavity. Research on esthesioneuroblastoma focuses on understanding its genetic and molecular characteristics to develop targeted therapies. Scientists are exploring novel treatment approaches such as immunotherapy and precision medicine to improve patient outcomes. Additionally, advancements in imaging techniques aid in early detection and accurate staging of the disease, enabling timely intervention. Collaborative efforts among oncologists, geneticists, and bioinformaticians are essential to unravel the complexities of esthesioneuroblastoma and devise personalized treatment strategies. Despite its rarity, ongoing research endeavors strive to enhance our understanding of this malignancy and pave the way for more effective therapies, offering hope to individuals affected by esthesioneuroblastoma.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp